Skip to main content

Advertisement

SpringerLink
Log in

Nutzen einer peri- und postoperativen Prostaglandingabe

Benefits of perioperative and postoperative administration of prostaglandin

  • Fragen aus der Praxis
  • Published:
Gefässchirurgie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Heise M, Krüger U, Pfitzmann R et al (2001) The influence of intraarterial prostaglandin E(1) on vascular hydraulic impedance and infrainguinal graft patency. Eur J Vasc Endovasc Surg 22:219–225

    Article  PubMed  CAS  Google Scholar 

  2. Ihnat DM, Duong ST, Taylor ZC et al (2008) Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. J Vasc Surg 47:967–974

    Article  PubMed  Google Scholar 

  3. Ikushima I, Hirai T, Ishii A, Yamashita Y (2008) Combined stent placement and high dose PGE1 drip infusion for chronic occlusion of the superficial femoral artery as a modality to salvage chronic critical limb ischemia. Eur J Radiol 66:95–99

    Article  PubMed  Google Scholar 

  4. Kawamura T, Nara N, Kadosaki M et al (2000) Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery. Crit Care Med 28:2201–2208

    Article  PubMed  CAS  Google Scholar 

  5. Laurila K, Lepäntalo M, Teittinen K et al (2004) Does an adjuvant AV-fistula improve the patency of a femorocrural PTFE bypass with distal vein cuff in critical leg ischaemia?–a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 27:180–185

    Article  PubMed  CAS  Google Scholar 

  6. Ljungman C, Ulus AT, Almgren B et al (2000) A multivariate analysis of factors affecting patency of femoropopliteal and femorodistal bypass grafting. Vasa 29:215–220

    Article  PubMed  CAS  Google Scholar 

  7. Melillo E, Nuti M, Buttitta F, Balbarini A (2006) Medical therapy in critical lower limb ischemia when immediate revascularization is not feasible. G Ital Cardiol (Rome) 7:317–335

    Google Scholar 

  8. Nehler MR, Brass EP, Anthony R et al (2007) Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg 45:953–960

    Article  PubMed  Google Scholar 

  9. Ruffolo AJ, Romano M, Ciapponi A (2010) Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev (1):CD006544

    Google Scholar 

  10. Schrör K, Hohlfeld T (2004) Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease. Vasa 33:119–124

    Article  PubMed  Google Scholar 

  11. Thul R, Heckenkamp J, Gawenda M et al (2007) The role of intra-operative Prostavasin application during crural bypass surgery. Zentralbl Chir 132:485–490

    Article  PubMed  CAS  Google Scholar 

  12. Ulus AT, Ljungman C, Almgren B et al (2001) The influence of distal runoff on patency of infrainguinal vein bypass grafts. Vasc Surg 35:31–35

    PubMed  CAS  Google Scholar 

  13. Wölfle KD, Bruijnen H, Loeprecht H et al (1992) Determination of vascular resistance in bypass operations with infragenual anastomosis: is prediction of early occlusion possible with this value? Vasa Suppl 36:35–41

    PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehung hin: Vorträge für UCB.

Author information

Authors and Affiliations

  1. Klinik für Gefäßmedizin, HELIOS Klinikum Krefeld, Lutherplatz 40, 47805, Krefeld, Deutschland

    K. Kröger & T. Nowak

  2. Chirurgische Abteilung, St. Rochus-Hospital, Castrop-Rauxel, Deutschland

    H. Böhner

  3. Klinik für Gefäßchirurgie, Universitätsklinik Düsseldorf, Düsseldorf, Deutschland

    K. Balzer

  4. Gefäßzentrum, Krankenhaus Merheim, Merheim, Deutschland

    M. Aleksic

  5. Gefäß- und endovaskuläre Chirurgie, Marienkrankenhaus Soest, Soest, Deutschland

    U. Klemp

  6. Gefäßchirurgie, Elisabeth-Krankenhaus Recklinghausen, Recklinghausen, Deutschland

    M. Pillny

  7. Praxis Gefäßchirurgie, Oberhausen, Deutschland

    S. Pourhassan

Authors
  1. K. Kröger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Böhner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Balzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Aleksic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Nowak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Klemp
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Pillny
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Pourhassan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Kröger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kröger, K., Böhner, H., Balzer, K. et al. Nutzen einer peri- und postoperativen Prostaglandingabe. Gefässchirurgie 17, 140–142 (2012). https://doi.org/10.1007/s00772-011-0944-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00772-011-0944-9

Search

Navigation